Table 2.
Patient characteristics | All samples (n = 96) | Gastritis ≤1 (n = 54) | Gastritis ≥2 (n = 42) |
---|---|---|---|
Female (%/number) | 78%/n = 75 | 76%/n = 41 | 81%/n = 34 |
Age (mean/median/range) | 41.1/42.0/19–64 | 42.6/44.0/19–64 | 39.3/39.5/24–59 |
Body mass index (kg/m2,, mean/median/range) | 39.91/39.20/32.70–53.50 | 40.28/39.55/32.70–53.50 | 39.43/39.00/34.00–48.90 |
Obesity (%) | 100 | 100 | 100 |
Healthy (apart from obesity, %/number) | 31%/n = 30 | 30%/n = 16 | 33%%/n = 14 |
Diabetes (type 1 or 2, %/number) | 10%/n = 10 | 7%/n = 4 | 14%/n = 6 |
Proton pump inhibitor treatment (%/number) | 9%/n = 9 | 6%/n = 3 | 14%/n = 6 |
Gastritis (histology score 0–5, mean/median/interquartile range) | 1.47/1.00/2.00 | 0.44/0.00/1.00 | 2.79/2.50/1.00 |
Leb (histology score 0–5, mean/median/interquartile range) | 1.54/2.00/2.00 | 1.30/1.00/2.00 | 1.86/2.00/2.00a |
Representative images for the Leb staining are shown in supplemental Fig. S1.
The Leb scores among patients with gastritis scores ≤1 were lower than from those with gastritis scores ≥2, Mann–Whitney U test, p < 0.05. Means and medians are presented together to nuance the data where applicable. The data presented as % were analyzed with Chi-square test, but no differences were significant between groups.